[Form 4] LEGGETT & PLATT INC Insider Trading Activity
Rhea-AI Filing Summary
Ryan Michael Kleiboeker, Executive Vice President–Chief Strategic Planning Officer at Leggett & Platt Inc. (LEG), reported purchases on 09/19/2025. The Form 4 shows two non-derivative acquisitions: 92.1962 shares at $7.973 and 212.7066 shares at $7.504, increasing his direct beneficial ownership to 84,660.0408 shares. Additional holdings disclosed: 1,000 shares held indirectly in a spouse's IRA and 862.061 shares held in trust under the issuer's retirement plan. The filing was signed by an attorney-in-fact on 09/22/2025.
Positive
- Insider purchases reported: Executive acquired 92.1962 shares at $7.973 and 212.7066 shares at $7.504 on 09/19/2025.
- Increased direct beneficial ownership to 84,660.0408 shares, improving disclosed alignment between management and shareholders.
- No derivative transactions reported, simplifying the ownership picture and reducing complexity around potential exercises or conversions.
Negative
- None.
Insights
TL;DR: Insider purchases by a senior executive indicate personal capital allocation into company stock, a routine but potentially confidence-signaling disclosure.
The reported purchases by an EVP are straightforward: two small open-market acquisitions at modest prices, raising direct holdings to 84,660.0408 shares. No options, warrants, or derivative transactions were reported, and indirect holdings are limited to an IRA and a retirement trust. This filing is procedural and provides transparency about insider ownership without revealing any new corporate strategy or material event.
TL;DR: Modest purchases by an officer reflect incremental accumulation; impact on valuation or control is immaterial.
The two reported acquisitions (92.1962 shares at $7.973 and 212.7066 shares at $7.504) are small in absolute terms relative to total outstanding shares and therefore unlikely to affect market dynamics or control. The transaction dates and prices are clearly reported and there are no amendments or derivative exercises. For investors, this is a routine disclosure confirming insider participation in the equity.